Ipilimumab in patients with melanoma and brain metastases
- PMID: 22748259
- DOI: 10.1016/S1470-2045(12)70303-0
Ipilimumab in patients with melanoma and brain metastases
Comment on
-
Ipilimumab in patients with melanoma and brain metastases: an open-label, phase 2 trial.Lancet Oncol. 2012 May;13(5):459-65. doi: 10.1016/S1470-2045(12)70090-6. Epub 2012 Mar 27. Lancet Oncol. 2012. PMID: 22456429 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
